China SXT Pharmaceuticals (SXTC) Competitors $0.43 +0.02 (+3.75%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends SXTC vs. CNSP, GLTO, KZIA, GRI, ADIL, ALZN, TRIB, GNPX, EVOK, and AEZSShould you be buying China SXT Pharmaceuticals stock or one of its competitors? The main competitors of China SXT Pharmaceuticals include CNS Pharmaceuticals (CNSP), Galecto (GLTO), Kazia Therapeutics (KZIA), GRI Bio (GRI), Adial Pharmaceuticals (ADIL), Alzamend Neuro (ALZN), Trinity Biotech (TRIB), Genprex (GNPX), Evoke Pharma (EVOK), and Aeterna Zentaris (AEZS). These companies are all part of the "pharmaceutical products" industry. China SXT Pharmaceuticals vs. CNS Pharmaceuticals Galecto Kazia Therapeutics GRI Bio Adial Pharmaceuticals Alzamend Neuro Trinity Biotech Genprex Evoke Pharma Aeterna Zentaris CNS Pharmaceuticals (NASDAQ:CNSP) and China SXT Pharmaceuticals (NASDAQ:SXTC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends. Does the media prefer CNSP or SXTC? In the previous week, CNS Pharmaceuticals' average media sentiment score of 0.00 equaled China SXT Pharmaceuticals'average media sentiment score. Company Overall Sentiment CNS Pharmaceuticals Neutral China SXT Pharmaceuticals Neutral Which has better earnings & valuation, CNSP or SXTC? China SXT Pharmaceuticals has higher revenue and earnings than CNS Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCNS PharmaceuticalsN/AN/A-$18.85M-$74.970.00China SXT Pharmaceuticals$1.93M0.90-$3.10MN/AN/A Is CNSP or SXTC more profitable? Company Net Margins Return on Equity Return on Assets CNS PharmaceuticalsN/A N/A -515.32% China SXT Pharmaceuticals N/A N/A N/A Which has more risk & volatility, CNSP or SXTC? CNS Pharmaceuticals has a beta of 2.52, suggesting that its share price is 152% more volatile than the S&P 500. Comparatively, China SXT Pharmaceuticals has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Do insiders & institutionals have more ownership in CNSP or SXTC? 14.0% of CNS Pharmaceuticals shares are held by institutional investors. Comparatively, 5.0% of China SXT Pharmaceuticals shares are held by institutional investors. 0.1% of CNS Pharmaceuticals shares are held by company insiders. Comparatively, 4.0% of China SXT Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community favor CNSP or SXTC? China SXT Pharmaceuticals received 35 more outperform votes than CNS Pharmaceuticals when rated by MarketBeat users. However, 71.21% of users gave CNS Pharmaceuticals an outperform vote while only 61.65% of users gave China SXT Pharmaceuticals an outperform vote. CompanyUnderperformOutperformCNS PharmaceuticalsOutperform Votes4771.21% Underperform Votes1928.79% China SXT PharmaceuticalsOutperform Votes8261.65% Underperform Votes5138.35% Do analysts rate CNSP or SXTC? CNS Pharmaceuticals currently has a consensus target price of $0.50, indicating a potential upside of 373.48%. Given CNS Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts plainly believe CNS Pharmaceuticals is more favorable than China SXT Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CNS Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00China SXT Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryCNS Pharmaceuticals beats China SXT Pharmaceuticals on 6 of the 11 factors compared between the two stocks. Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTC vs. The Competition Export to ExcelMetricChina SXT PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.67M$6.57B$5.39B$9.13BDividend YieldN/A2.96%5.37%4.00%P/E RatioN/A10.0188.9117.53Price / Sales0.90315.791,280.48134.21Price / CashN/A22.6336.6032.90Price / Book0.015.084.964.69Net Income-$3.10M$154.90M$117.89M$224.57M7 Day Performance8.46%1.33%1.68%1.69%1 Month Performance33.06%1.52%3.63%5.34%1 Year Performance-73.88%4.60%26.16%21.47% China SXT Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTCChina SXT Pharmaceuticals0.0781 of 5 stars$0.43+3.8%N/A-75.0%$1.67M$1.93M0.0090Positive NewsGap DownCNSPCNS Pharmaceuticals1.9562 of 5 stars$0.12-0.7%$0.50+327.4%-99.7%$6.73MN/A0.005News CoveragePositive NewsGLTOGalecto3.3067 of 5 stars$5.09-0.8%$10.00+96.5%-65.0%$6.70MN/A-0.2740Positive NewsKZIAKazia Therapeutics3.1871 of 5 stars$1.51-4.4%$20.00+1,224.5%-58.9%$6.58M$2.31M0.0012Gap UpGRIGRI Bio2.7518 of 5 stars$0.73-4.3%$11.50+1,475.3%-97.2%$6.52MN/A-0.781ADILAdial Pharmaceuticals3.1295 of 5 stars$1.01-1.0%$8.00+692.1%-23.7%$6.47MN/A0.0020Positive NewsGap DownALZNAlzamend Neuro2.3283 of 5 stars$1.15+1.8%$32.00+2,682.6%-86.6%$6.25MN/A0.004Positive NewsTRIBTrinity Biotech1.507 of 5 stars$0.82-2.0%N/A-63.0%$6.25M$59.13M-0.36480Positive NewsGNPXGenprex4.24 of 5 stars$0.73-6.4%$10.00+1,269.7%-91.7%$6.21MN/A0.0020Positive NewsEVOKEvoke Pharma0.812 of 5 stars$4.17-0.7%N/A-51.7%$6.20M$8.62M-0.384Positive NewsAEZSAeterna ZentarisN/A$3.40+5.7%N/A-62.5%$6.10M$2.37M-0.2320Analyst Forecast Related Companies and Tools Related Companies CNS Pharmaceuticals Alternatives Galecto Alternatives Kazia Therapeutics Alternatives GRI Bio Alternatives Adial Pharmaceuticals Alternatives Alzamend Neuro Alternatives Trinity Biotech Alternatives Genprex Alternatives Evoke Pharma Alternatives Aeterna Zentaris Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SXTC) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China SXT Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
